Ortin Laboratories [ORTINLAB] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Ortin Laboratories
NSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ortin Laboratories wins in 3 metrics, Sun Pharmaceutical wins in 15 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ortin Laboratories | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 48.33 | 37.37 | Sun Pharmaceutical |
| Price-to-Book Ratio | 5.86 | 5.42 | Sun Pharmaceutical |
| Debt-to-Equity Ratio | 63.82 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | -0.64 | 49.94 | Ortin Laboratories |
| EV/EBITDA | -2.30 | 24.15 | Ortin Laboratories |
| Profit Margin (TTM) | 43.70% | 19.29% | Ortin Laboratories |
| Operating Margin (TTM) | -49.76% | 24.34% | Sun Pharmaceutical |
| EBITDA Margin (TTM) | N/A | 24.34% | N/A |
| Return on Equity | -0.86% | 15.08% | Sun Pharmaceutical |
| Return on Assets (TTM) | -0.44% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $-2.53M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | N/A | 1.26% | N/A |
| 1-Year Return | -10.03% | -8.07% | Sun Pharmaceutical |
| Price-to-Sales Ratio (TTM) | 22.11 | 7.28 | Sun Pharmaceutical |
| Enterprise Value | $155.99M | $3,703.82B | Sun Pharmaceutical |
| EV/Revenue Ratio | 20.82 | 6.89 | Sun Pharmaceutical |
| Gross Profit Margin (TTM) | 49.09% | 79.58% | Sun Pharmaceutical |
| Revenue per Share (TTM) | $1 | $224 | Sun Pharmaceutical |
| Earnings per Share (Diluted) | $-10.04 | $43.67 | Sun Pharmaceutical |
| Beta (Stock Volatility) | 1.36 | 0.31 | Sun Pharmaceutical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ortin Laboratories vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ortin Laboratories | -5.04% | 17.43% | 46.89% | 62.63% | 8.12% | -2.35% |
| Sun Pharmaceutical | -0.72% | -6.35% | -4.85% | -10.27% | -8.65% | -15.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ortin Laboratories | -10.03% | -23.76% | -20.04% | -33.69% | -33.69% | -33.69% |
| Sun Pharmaceutical | -8.07% | 74.63% | 200.22% | 77.70% | 811.07% | 2,672.33% |
Performance & Financial Health Analysis: Ortin Laboratories vs Sun Pharmaceutical
| Metric | ORTINLAB | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹165.64M | ₹3.92T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 14,317 | 2,473,887 |
| 90 Day Avg. Volume | 20,463 | 2,177,422 |
| Last Close | ₹16.57 | ₹1,586.90 |
| 52 Week Range | ₹9.64 - ₹24.82 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -33.24% | -19.05% |
| All-Time High | ₹87.92 (Dec 07, 2015) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -81.15% | -19.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.87% | 0.10% |
| Quarterly Earnings Growth | N/A | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.44% | 0.19% |
| Operating Margin (TTM) | -0.50% | 0.24% |
| Return on Equity (TTM) | -0.01% | 0.15% |
| Debt to Equity (MRQ) | 63.82 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹3.48 | ₹300.99 |
| Cash per Share (MRQ) | ₹2.96 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹-12,544,000 | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹-936,000 | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.26% |
| Last 12-Month Dividend | N/A | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Ortin Laboratories vs Sun Pharmaceutical
| Metric | ORTINLAB | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 48.33 | 37.37 |
| Forward P/E | N/A | 49.94 |
| PEG Ratio | -0.64 | 49.94 |
| Price to Sales (TTM) | 22.11 | 7.28 |
| Price to Book (MRQ) | 5.86 | 5.42 |
| Market Capitalization | ||
| Market Capitalization | ₹165.64M | ₹3.92T |
| Enterprise Value | ₹155.99M | ₹3.70T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 20.82 | 6.89 |
| Enterprise to EBITDA | -2.30 | 24.15 |
| Risk & Other Metrics | ||
| Beta | 1.36 | 0.31 |
| Book Value per Share (MRQ) | ₹3.48 | ₹300.99 |
Financial Statements Comparison: Ortin Laboratories vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ORTINLAB | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹2.09M | ₹137.86B |
| Cost of Goods Sold | ₹1.06M | ₹28.15B |
| Gross Profit | ₹1.02M | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-1.01M | ₹33.72B |
| EBITDA | ₹-964,000 | ₹47.66B |
| Pre-Tax Income | ₹-1.01M | ₹31.73B |
| Income Tax | ₹17,000 | ₹8.70B |
| Net Income (Profit) | ₹-1.03M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ORTINLAB | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹3.17M | ₹102.69B |
| Total Current Assets | ₹37.21M | ₹526.24B |
| Total Current Liabilities | ₹55.54M | ₹181.94B |
| Long-Term Debt | ₹26.16M | ₹3.58B |
| Total Shareholders Equity | ₹97.61M | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | ₹138.43M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ORTINLAB | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ORTINLAB | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 14,317 | 2,473,887 |
| Average Daily Volume (90 Day) | 20,463 | 2,177,422 |
| Shares Outstanding | 8.13M | 2.40B |
| Float Shares | 5.40M | 1.04B |
| % Held by Insiders | 0.27% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Ortin Laboratories vs Sun Pharmaceutical
| Metric | ORTINLAB | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹21.00 |
| Last 12-Month Dividend Yield | N/A | 1.26% |
| 3-Year Avg Annual Dividend | N/A | ₹14.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | N/A | ₹44.00 |
| Ex-Dividend Date | N/A | Jul 07, 2025 |